Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
Conditions: Glioblastoma; Molecular Disease Intervention: Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA Sponsor: Centre Hospitalier Universitaire, Amiens Recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospital Management